Alkylphospho-L-serine analogues: Synthesis of cytostatically active alkylphosphono derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 13, 1997, Pages 1739-1742

  Brachwitz, H ^a   Olke M ^a   Bergmann, J ^a   Langen, P ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA O HEXADECYLPHOSPHONO ALANINE; CYTOSTATIC AGENT; HEXADECYLPHOSPHONO SERINE; PHOSPHOLIPID; PHOSPHOSERINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; DRUG SYNTHESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; PHOSPHOLIPID MEMBRANE; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

EID: 0343118163     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00301-6     Document Type: Article

References (23)

1. Munder, P. G.; Westphal, O. Antitumoral and other biomedical activities of synthetic ether lysophospholipids. In: 1939-1989: Fifty Years Progress in Allergy. Chem. Immunol. Waksman, B. H. Ed. Karger: Basel, 1990, pp 206-235.
2. (a) Zeisig, R.; Arndt, D.; Brachwitz, H. Pharmazie. 1990, 45, 809-818.;
3. (b) Berdel, W. E. Br. J. Cancer 1991, 64, 208-211.;
4. (c) Brachwitz, H.; Vollgraf, C. Pharmacol. Ther. 1995, 66, 39-82.
5. (a) Tsakiris, S.; Deliconstantinos, G. Biochem. J. 1984, 220, 301-307.;
6. (b) Buckmann, T. D.; Eidusono, S.; Boscia, R. Biochem. Pharmacol. 1983, 32, 3639-3647.;
7. (c) Choy, F. Y. Hum. Genet. 1984, 67, 432-436.
8. Nishizuka, Y. Science 1984, 225, 1365-1370.
9. Paltauf, F.; Brachwitz, H.; Hermetter, A,; Überall, F.; Egle, A.; Grunicke, H. Cancer Res. Clin. Oncol. (Supplement) 1990, 116, 888.
10. Langen, P.; Maurer, H. R.; Brachwitz, H.; Eckert, K.; Veit, A.; Vollgraf, C. Anticancer Res. 1992, 12, 2109-2112.
11. (a) Junghahn, I.; Bergmann, J.; Langen, P.; Thun, I.; Vollgraf, C.; Brachwitz, H. Anticancer Res. 1995, 15, 449-454.;
12. (b) Bergmann, J.; Junghahn, I.; Brachwitz, H.; Langen, P. Anticancer Res. 1994, 14, 1549-1556,;
13. (c) Bergmann, J.; Junghahn, I.; Brachwitz, H.; Vollgraf, C.; Langen, P. J. Lipid Mediators. Cell Signal. 1996, in press;
14. (d) Maly, K.; Überall, F.; Schubert, C.; Kindler, E.; Stekar, J.; Brachwitz, H.; Grunicke, H. H. Anti-Cancer Drug Design 1995, 10, 411-425.;
15. (e) Grunicke, H. H.; Maly, K.; Überall, F.; Schubert, C.; Kindler, E.; Stekar, J.; Brachwitz, H. Advan. Enzyme Regul. 1996, 36, 385-407.
16. Comfurius, P.; Zwaal, R. F. A. Biochim. Biophys. Acta 1977, 488, 36-42.
17. Brachwitz, H.; Langen, P.; Dube, G; Schildt, J.; Paltauf, F.; Hermetter, A. Chem. Phys. Lipids 1990, 54, 89-98.
18. Brachwitz, H.; von Janta-Lipinski, M. Deutsches Patent DD 279 249 1990.
19. Davidson, F. M.; Long, C. Biochem. J. 1958, 69, 458-466.
20. Solvent A: chloroform-methanol-acetone-acetic acid-water 50:10:20:10:5; solvent B: chloroform-methanol-acetic acid-water 50:30:4:8); solvent C: chloroform-methanol-water-acetic acid 25:5:4:2; solvent D: hexane-ethyl acetate 7:3; solvent E: chloroform-methanol 6:1.
21. Brachwitz, H.; Schönfeld, R.; Langen, P.; Paltauf, F.; Hermetter, A., 1989, Europ. Patent 0 338 407.
22. Monsigny, M.L.P.; Delay, D.; Vaculik, M. Carbohydrate Research 1977, 59, 589-593.
23. Effimov, V. A.; Reverdatto, S. V.; Chakhmakhcheva, O. G. Tetrahedron Lett. 1982, 9, 9661-9644.